Visualize the Future
Where Innovation Meets Clarity
Blindness is the most feared human disability.
Each year, more than 185,000 cases of blindness caused by corneal problems are cured by traditional forms of transplantation.
12.7 millions cases are currently waiting for transplantation, and at least 8000 per year are destined to fail. Either because they cannot be treated by traditional methods or because of lack of donors.
Our research is creating the Alternative.
→
INTRA-KER ALTERNATIVE
Traditional corneal transplantation faces significant challenges, including immune rejection, endothelial cell loss, and risk of infection. INTRA-KER is addressing these limitations with a groundbreaking solution: a hybrid intracorneal device that combines cutting-edge scientific innovation with a novel design approach.
Our hybrid intracorneal device is
EXTRAOCULAR for safe implantation
STABLE allowing storage > 12 months
TRANSPARENT for light transmission
ACELLULAR obviating risk of immune rejection
BIOLOGIC for stable bio-integration
INDEPENDENT of endothelial function
ALSO SEEN IN
INTRA-KER Video Library
All Videos
RASHA COLPITA DA UNA BOMBA A GAZA TORNA A VEDERE GRAZIE ALLA PRIMA CORNEA ARTIFICIALE | 10/10/2024
Rasha, rifugiata palestinese, torna a vedere grazie a prima cornea artificiale ibrida made in Italy
